A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab
Clinical trial NCT04302324 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04302324
- Sponsor
- Weill Medical College of Cornell University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-28
- Primary completion
- 2024-05-31
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.